title: Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy.
authors.affiliation: Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts.
authors.forename: Danielle
authors.initials: D
authors.lastname: Levine
authors.affiliation: Division of Endocrinology, Boston University School of Medicine, Boston, Massachusetts.
authors.forename: Sonia
authors.initials: S
authors.lastname: Ananthakrishnan
authors.affiliation: Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts. Electronic address: agarg@bu.edu.
authors.forename: Amit
authors.initials: A
authors.lastname: Garg
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000309:Adrenal Insufficiency / Q000139:chemically induced; D000328:Adult; D000069446:Atazanavir Sulfate; D003480:Cushing Syndrome / Q000139:chemically induced*; D065607:Cytochrome P-450 Enzyme Inhibitors; D005260:Female; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007049:Iatrogenic Disease; D007273:Injections, Intramuscular; D019259:Lamivudine / Q000627:therapeutic use; D009842:Oligopeptides / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D000068698:Tenofovir; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D063065:Organophosphonates; D011725:Pyridines; D019259:Lamivudine; D000069446:Atazanavir Sulfate; D000068698:Tenofovir; D014222:Triamcinolone Acetonide; D000225:Adenine; D019438:Ritonavir